Testing is one piece of reopening, but experts are still relying on the help of a vaccine to keep the public safe. Researchers are increasingly optimistic that scientists are getting closer to development even though we’re barely months into identifying and learning about the novel strain of SARS. Human and clinical trials are well underway, but just when they’ll be ready for manufacturing and distribution is another story. What is a realistic timeline and does one exist? We asked Dr. Vincent Silenzio an expert in urban and global public health at Rutgers University. To read the full story.
Recent Posts
- Landmark Data from Rutgers Cancer Institute and RWJBarnabas Health Show Long-term Complete Responses of T Cell Therapies for HPV-Related Cancers.
- NJACTS Community Engagement Core Available Services
- Why Your Daily Walk Might Not Work as Well if You’re on Metformin.
- In the hallways of Princeton, a fascination with the human mind unlocked the power of deep learning.
- Rutgers Is Awarded $3.75 Million Federal Grant to Prepare Future Special Education Leaders.
Categories
- Community (2,397)
- Covid (993)
- CTO Events (6)
- News (3,035)
- Pilots (21)